Worldwide delivery in 2 to 3 business days. Shipping details

Semax 10 mg pen

Neurological, pen

Semax

ACTH(4-7) heptapeptide with Pro-Gly-Pro tail; rapid intranasal CNS uptake and BDNF/NGF mRNA upregulation in hippocampus.

€83.90

Sold out

10 mg is sold out right now. Stock is checked hourly.

Subscribe to our newsletter and enjoy 10% off

Seller
Sold and shipped by Purita Peptides, the seller of record. You pay on their secure checkout.
In the box
1 x Pre-Formulated Peptide Pen
Format
Pen
Storage
Keep refrigerated at 2°C to 8°C. Do not freeze. Keep away from direct light.
Delivery
Worldwide, tracked and insured, 2 to 3 business days after dispatch. Dispatched within 1 to 2 business days of payment. Shipping details
Certificate
None published for this product yet. See what is available
Use
For laboratory research only. Not for human or animal use.

Semax, 10 mg

€83.90

Notify me

Specification

Molecular weight
813.93 Da
Half-life
3 min
Research area
Neuropeptide
Format
Pen

Also called ACTH(4-7)PGP, MEHFPGP heptapeptide

Parent peptide plasma t½ ~2–5 min (intranasal/IV, rat). Active metabolite Pro-Gly-Pro accumulates in brain with substantially longer t½, contributing to durable behavioral effects (>20 h post-IN dose).

Sequence M E H F P G P

Certificate of analysis

Purita Peptides has not published a certificate for Semax yet. We list a certificate only once the document exists and we have opened it. See which products have certificates.

About the research

Semax is a Russian-developed neuropeptide synthesized at the Institute of Molecular Genetics by Ashmarin and colleagues from the ACTH(4-7) fragment. Listed on Russia's Vital and Essential Drugs List and used in clinical neurology for stroke and cognitive indications, it is studied as a non-melanocortin ACTH derivative with neurotrophic, dopaminergic, and pro-cognitive effects mediated in part through its Pro-Gly-Pro metabolite.

Mechanism, reported research areas, literature dose ranges and co-factor studies are on the research page, with sources. Nothing there is a claim about this product.

Read the Semax research overview
  • Ischemic stroke neuroprotection models
  • BDNF and NGF upregulation studies in hippocampus
  • Attention, memory, and cognitive performance rodent assays
  • Optic-nerve neuropathy and visual-pathway research
  • Reported research areas, from the literature. Not product claims.

More research compounds

All products

Subscribe to our newsletter and enjoy 10% off

New products, restocks and offers. Your code is shown straight away and emailed to you. Unsubscribe with one click.

Analytics cookies

With your permission we use Google Analytics to see which pages and products are useful. It sets cookies. Our own measurement is cookieless and runs either way. Details in the cookie policy.